Statement Of Changes In Equity [Abstract]

Captor Therapeutics S.A. - Filing #6216905

Concept As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
As at
2020-01-01
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity
58 208 PLN
175,000 PLN
124 201 PLN
124 201 PLN
170 031 PLN
11,000 PLN
413,000 PLN
11 779 PLN
7,000 PLN
359,000 PLN
1 004 PLN
25 636 PLN
5 690 PLN
16 292 PLN
1 004 PLN
2 284 PLN
25,636,000 PLN
1,004,000 PLN
359,000 PLN
7,000 PLN
16,292,000 PLN
5 690 PLN
2,284,000 PLN
1 004 PLN
550,000 PLN
359,000 PLN
4 277 PLN
18,000 PLN
12 942 PLN
16 292 PLN
4 277 PLN
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)
32 572 PLN
32 572 PLN
32 572 PLN
12 694 PLN
12 694 PLN
12 694 PLN
Other comprehensive income
38,000 PLN
42,000 PLN
4,000 PLN
42,000 PLN
42,000 PLN
35,000 PLN
7,000 PLN
42,000 PLN
Comprehensive income
38,000 PLN
32 530 PLN
4,000 PLN
32 530 PLN
32 572 PLN
12 652 PLN
12 694 PLN
35,000 PLN
7,000 PLN
12 652 PLN
Issue of equity
5 601 PLN
148 240 PLN
153 739 PLN
102,000 PLN
148 240 PLN
5 600 PLN
5 600 PLN
5 600 PLN
Increase (decrease) through share-based payment transactions, equity
9 495 PLN
9 495 PLN
9 495 PLN
1 734 PLN
1 734 PLN
1 734 PLN

Talk to a Data Expert

Have a question? We'll get back to you promptly.